MF
ROIVW

Magnetar Financial’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Magnetar Financial’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,040,021
Closed -$5.06M – 653
2023
Q2 		$5.06M Buy
2,040,021
+37,585
+2% +$74K 0.11% 123
2023
Q1 		$2.92M Buy
2,002,436
+44,497
+2% +$82.6K 0.06% 240
2022
Q4 		$3.8M Buy
1,957,939
+409,976
+26% +$449K 0.06% 295
2022
Q3 		$604K Sell
1,547,963
-99,041
-6% -$52.7K 0.01% 794
2022
Q2 		$988 Buy
1,647,004
+199,926
+14% +$105K 0.01% 977
2022
Q1 		$1.35M Buy
1,447,078
+98,294
+7% +$125K 0.01% 747
2021
Q4 		$2.77M Buy
+1,348,784
New +$2.06M 0.03% 601

Magnetar Financial's ROIVW Position: Q3 2023 in Review

Magnetar Financial sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 2,040,021 shares — an estimated $5.06M sold.

Magnetar Financial first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $5.06M in Q2 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

  • Magnetar Financial reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
  • Magnetar Financial sold 2,040,021 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $5.06M.
  • Magnetar Financial first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
  • Magnetar Financial's Roivant Sciences Ltd. Warrant position peaked at $5.06M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Magnetar Financial's 13F filing for Q3 2023, filed 14 Nov 2023.